fda-approved hiv-1 protease inhibitors (MultiTarget Pharmaceuticals)
90
Structured Review
MultiTarget Pharmaceuticals
fda-approved hiv-1 protease inhibitors
Fda Approved Hiv 1 Protease Inhibitors, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fda-approved+hiv-1+protease+inhibitors/multitarget+ribozyme+directed+to+cleave+at+up+to+nine+highly+conserved+hiv+1+env+rna+regions/pmc07665348-60-14-34
Average 90 stars, based on 1 article reviews
Fda Approved Hiv 1 Protease Inhibitors, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fda-approved+hiv-1+protease+inhibitors/multitarget+ribozyme+directed+to+cleave+at+up+to+nine+highly+conserved+hiv+1+env+rna+regions/pmc07665348-60-14-34
Average 90 stars, based on 1 article reviews
fda-approved hiv-1 protease inhibitors - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
In Silico:Article Title: A review on drug repurposing applicable to COVID-19 Article Snippet: Ekins et al. [ ] , Docking with 3 different programs , For main protease: FDA-approved HIV-1 protease inhibitors and hepatitis C NS3/4A protease inhibitors (16 compounds).For spike: FDA-approved drugs (ca. 2400 molecules) , |